147 related articles for article (PubMed ID: 11570642)
1. Role of IL-18 in the secretion of Il-1beta, sIL-1RII, and IL-1Ra by human neutrophils.
Jablonska E; Izycka A; Jablonska J; Wawrusiewicz N; Piecuch J
Immunol Invest; 2001 Aug; 30(3):221-9. PubMed ID: 11570642
[TBL] [Abstract][Full Text] [Related]
2. Effect of IL-18 on IL-1beta and sIL-1RII production by human neutrophils.
Jabłońska E; Izycka A; Wawrusiewicz N
Arch Immunol Ther Exp (Warsz); 2002; 50(2):139-41. PubMed ID: 12022703
[TBL] [Abstract][Full Text] [Related]
3. Effect of IL-15 on the secretion of IL-1beta, IL-1Ra and sIL-1RII by PMN from cancer patients.
Jablonska E; Piotrowski L; Kiluk M; Jablonski J; Grabowska Z; Markiewicz W
Cytokine; 2001 Dec; 16(5):173-7. PubMed ID: 11814312
[TBL] [Abstract][Full Text] [Related]
4. IL-1beta, IL-1Ra and sIL-1RII in the culture supernatants of PMN and PBMC and the serum levels in patients with inflammation and patients with cancer disease of the same location.
Jablonska E; Jablonski J; Piotrowski L; Grabowska Z
Immunobiology; 2001 Dec; 204(4):508-16. PubMed ID: 11776404
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid sensitivity of interleukin-1 agonist and antagonist secretion: the effects of age and gender.
Daun JM; Ball RW; Cannon JG
Am J Physiol Regul Integr Comp Physiol; 2000 Apr; 278(4):R855-62. PubMed ID: 10749772
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1beta, interleukin-1 receptor antagonist, and interleukin-1 soluble receptor II in temporomandibular joint synovial fluid from patients with chronic polyarthritides.
Alstergren P; Benavente C; Kopp S
J Oral Maxillofac Surg; 2003 Oct; 61(10):1171-8. PubMed ID: 14586853
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.
Ricote M; García-Tuñón I; Bethencourt FR; Fraile B; Paniagua R; Royuela M
Cancer; 2004 Apr; 100(7):1388-96. PubMed ID: 15042672
[TBL] [Abstract][Full Text] [Related]
8. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
[TBL] [Abstract][Full Text] [Related]
9. Aspirin-induced increases in soluble IL-1 receptor type II concentrations in vitro and in vivo.
Daun JM; Ball RW; Burger HR; Cannon JG
J Leukoc Biol; 1999 Jun; 65(6):863-6. PubMed ID: 10380911
[TBL] [Abstract][Full Text] [Related]
10. The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type II.
Kreuzer KA; Dayer JM; Rockstroh JK; Sauerbruch T; Spengler U
Clin Exp Immunol; 1997 Jul; 109(1):54-8. PubMed ID: 9218824
[TBL] [Abstract][Full Text] [Related]
11. [Concentration of interleukin-18, interleukin-1beta, soluble receptor for interleukin-1 (sIL-1RII) and C-reactive protein in patients with neuroborreliosis].
Pietruczuk A; Swierzbińska R; Pietruczuk M; Kondrusik M; Zajkowska J; Pancewicz S; Hermanowska-Szpakowicz T
Neurol Neurochir Pol; 2005; 39(1):33-9. PubMed ID: 15735988
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta.
Malyak M; Smith MF; Abel AA; Arend WP
J Clin Immunol; 1994 Jan; 14(1):20-30. PubMed ID: 8132734
[TBL] [Abstract][Full Text] [Related]
13. The differential production of three forms of IL-1 receptor antagonist by human neutrophils and monocytes.
Malyak M; Smith MF; Abel AA; Hance KR; Arend WP
J Immunol; 1998 Aug; 161(4):2004-10. PubMed ID: 9712073
[TBL] [Abstract][Full Text] [Related]
14. [Role of interleukin-18, interleukin-1beta and its soluble receptor (sIL-1RII) in early and late Lyme borreliosis].
Pietruczuk A; Swierzbińska R; Pietruczuk M; Hermanowska-Szpakowicz T
Pol Merkur Lekarski; 2004 Nov; 17(101):446-50. PubMed ID: 15754629
[TBL] [Abstract][Full Text] [Related]
15. Endotoxin-adapted septic shock leukocytes selectively alter production of sIL-1RA and IL-1beta.
Mueller LP; Yoza BK; Neuhaus K; Loeser CS; Cousart S; Chang MC; Meredith JW; Li L; McCall CE
Shock; 2001 Dec; 16(6):430-7. PubMed ID: 11770040
[TBL] [Abstract][Full Text] [Related]
16. Relative cytokine and cytokine inhibitor production by mononuclear cells and neutrophils.
Xing L; Remick DG
Shock; 2003 Jul; 20(1):10-6. PubMed ID: 12813362
[TBL] [Abstract][Full Text] [Related]
17. Effect of IL-18 on the release of IL-6 and its soluble receptors: sIL-6Ralpha and sgp130 by human neutrophils.
Jablonska E; Jablonski J
Immunol Invest; 2002; 31(3-4):159-67. PubMed ID: 12472176
[TBL] [Abstract][Full Text] [Related]
18. IL-1 beta, IL-1 receptor antagonist and soluble type II IL-1 receptor in synovial fluid of patients with temporomandibular disorders.
Tominaga K; Habu M; Sukedai M; Hirota Y; Takahashi T; Fukuda J
Arch Oral Biol; 2004 Jun; 49(6):493-9. PubMed ID: 15099807
[TBL] [Abstract][Full Text] [Related]
19. Functional genomic analysis of type II IL-1beta decoy receptor: potential for gene therapy in human arthritis and inflammation.
Attur MG; Dave MN; Leung MY; Cipolletta C; Meseck M; Woo SL; Amin AR
J Immunol; 2002 Feb; 168(4):2001-10. PubMed ID: 11823537
[TBL] [Abstract][Full Text] [Related]
20. Cell density regulates neutrophil IL-8 synthesis: role of IL-1 receptor antagonist and soluble TNF receptors.
Hattar K; Fink L; Fietzner K; Himmel B; Grimminger F; Seeger W; Sibelius U
J Immunol; 2001 May; 166(10):6287-93. PubMed ID: 11342652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
